en

PRODUCT DETAIL

Kigabeq 100 mg rozpustné tablety

Code 9538C
MA number EU/1/18/1302/001
Product Form: tbl sol 100x100 mg (fľ.HDPE)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 21 - ANTIEPILEPTICA, ANTICONVULSIVA
ATC:
N NERVOUS SYSTEM
N03 ANTIEPILEPTICS
N03A ANTIEPILEPTICS
N03AG Fatty acid derivatives
N03AG04 Vigabatrin
Shelf life: 48
Container: bottle HDPE
Route of admin.: Oral or gastrointestinal use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(3) hybrid application
MA issued: 20.09.2018
Validity: 20.09.2023
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 13.05.2021
eu-flag.png sk-flag.png